Auriga Maintains a 'Buy' on Thermo Fisher Scientific (TMO); Instruments and Consumables Performed Well

Auriga maintains a 'Buy' on Thermo Fisher Scientific (NYSE: TMO) price target of $65.00.

Analyst, Peter McDonald, said, "Revenue and EPS were above consensus and our estimates. Organic revenue growth of 4% was ahead of our expectations (2%) as new product launches, solid demand in emerging and applied markets helped. Global demand remains steady with continued strength in industrial, applied and clinical diagnostic markets, but weakness in Academic and Government continued (down low single digits). Overall, TMO's diverse end markets continue to help offset lingering weakness within Academic/Government."

For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.

Shares of Thermo Fisher Scientific closed at $55.07 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
• SoundThinking (SSTI) PT Lowered to $8 at Cantor Fitzgerald
• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform